Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,969 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multistate modelling to estimate excess length of stay and risk of death associated with organ/space infection after elective colorectal surgery.
Shaw E, Gomila A, Piriz M, Perez R, Cuquet J, Vazquez A, Badia JM, Lérida A, Fraccalvieri D, Marron A, Freixas N, Castro A, Cruz A, Limón E, Gudiol F, Biondo S, Carratalà J, Pujol M; VINCat colon surgery group. Shaw E, et al. Among authors: perez r. J Hosp Infect. 2018 Dec;100(4):400-405. doi: 10.1016/j.jhin.2018.08.010. Epub 2018 Aug 17. J Hosp Infect. 2018. PMID: 30125586
Risk factors and outcomes of organ-space surgical site infections after elective colon and rectal surgery.
Gomila A, Carratalà J, Camprubí D, Shaw E, Badia JM, Cruz A, Aguilar F, Nicolás C, Marrón A, Mora L, Perez R, Martin L, Vázquez R, Lopez AF, Limón E, Gudiol F, Pujol M; VINCat colon surgery group. Gomila A, et al. Among authors: perez r. Antimicrob Resist Infect Control. 2017 Apr 21;6:40. doi: 10.1186/s13756-017-0198-8. eCollection 2017. Antimicrob Resist Infect Control. 2017. PMID: 28439408 Free PMC article.
Predictive factors for early- and late-onset surgical site infections in patients undergoing elective colorectal surgery. A multicentre, prospective, cohort study.
Gomila A, Carratalà J, Biondo S, Badia JM, Fraccalvieri D, Shaw E, Diaz-Brito V, Pagespetit L, Freixas N, Brugués M, Mora L, Perez R, Sanz C, Arroyo N, Iftimie S, Limón E, Gudiol F, Pujol M; VINCat colon surgery group. Gomila A, et al. Among authors: perez r. J Hosp Infect. 2018 May;99(1):24-30. doi: 10.1016/j.jhin.2017.12.017. Epub 2017 Dec 28. J Hosp Infect. 2018. PMID: 29288776
Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study.
Gomila A, Carratalà J, Badia JM, Camprubí D, Piriz M, Shaw E, Diaz-Brito V, Espejo E, Nicolás C, Brugués M, Perez R, Lérida A, Castro A, Biondo S, Fraccalvieri D, Limón E, Gudiol F, Pujol M; VINCat Colon Surgery Group. Gomila A, et al. Among authors: perez r. BMC Infect Dis. 2018 Oct 5;18(1):507. doi: 10.1186/s12879-018-3413-1. BMC Infect Dis. 2018. PMID: 30290773 Free PMC article.
Decreased mortality among patients with catheter-related bloodstream infections at Catalan hospitals (2010-2019).
Badia-Cebada L, Peñafiel J, López-Contreras J, Pomar V, Martínez JA, Santana G, Cuquet J, Montero MM, Hidalgo-López C, Andrés M, Gimenez M, Quesada MD, Vaqué M, Iftimie S, Gudiol C, Pérez R, Coloma A, Marron A, Barrufet P, Marimon M, Lérida A, Clarós M, Ramírez-Hidalgo MF, Garcia Pardo G, Martinez MJ, Chamarro EL, Jiménez-Martínez E, Hornero A, Limón E, López M, Calbo E, Pujol M, Gasch O; Surveillance of health-care associated infections in Catalonia (VINCat). Badia-Cebada L, et al. Among authors: perez r. J Hosp Infect. 2022 Aug;126:70-77. doi: 10.1016/j.jhin.2022.05.009. Epub 2022 May 18. J Hosp Infect. 2022. PMID: 35594988
Clostridioides difficile infection recurrence in the VINCat hospitals: a prospective observational cohort study.
Pujol M, Limón E, Sopena N, Lopez-Contreras J, Castellá L, Cuquet J, López-Sánchez M, Pérez R, Gudiol C, Coloma A, Marimón M, Espinach J, Andres M, Martos P, Hernández S, Almendral A, Saliba P, Rodrigues GC, Calbo E, Group VP. Pujol M, et al. Among authors: perez r. Future Microbiol. 2022 Dec;17:1445-1453. doi: 10.2217/fmb-2022-0076. Epub 2022 Oct 31. Future Microbiol. 2022. PMID: 36314417
Late poor outcomes of Clostridioides difficile infections in oncological patients: A multicentre cohort study.
Calbo E, Hernández S, Sopena N, Castellá L, Lopez-Contreras J, Cuquet J, López-Sánchez M, Pérez R, Gudiol C, Coloma A, Marimón M, Espinach J, Andres M, Martos P, Carvalho Rodrigues G, Limón E. Calbo E, et al. Among authors: perez r. J Infect Prev. 2023 Jul;24(4):182-186. doi: 10.1177/17571774231165410. Epub 2023 Mar 21. J Infect Prev. 2023. PMID: 37333870 Free PMC article.
A multimodal intervention program to control a long-term Acinetobacter baumannii endemic in a tertiary care hospital.
Valencia-Martín R, Gonzalez-Galan V, Alvarez-Marín R, Cazalla-Foncueva AM, Aldabó T, Gil-Navarro MV, Alonso-Araujo I, Martin C, Gordon R, García-Nuñez EJ, Perez R, Peñalva G, Aznar J, Conde M, Cisneros JM; In representation of A. baumannii eradication program. Valencia-Martín R, et al. Among authors: perez r. Antimicrob Resist Infect Control. 2019 Dec 4;8:199. doi: 10.1186/s13756-019-0658-4. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31827780 Free PMC article.
Real-World Experience in Tricuspid Transcatheter Edge-to-Edge Repair: Transcatheter Tricuspid Valve Repair in Spain Registry.
Sisinni A, Barreiro-Perez M, Freixa X, Arzamendi D, Moñivas V, Carrasco-Chinchilla F, Pan M, Nombela-Franco L, Pascual I, Benito-González T, Perez R, Gómez-Blázquez I, Amat-Santos IJ, Cruz-González I, Sánchez-Recalde Á, Alvarez ABC, Sanchis L, Caneiro-Queija B, Li CH, Del Trigo M, Martínez-Carmona JD, Mesa D, Pozo E, Avanzas P, Cepas-Guillén P, Estévez-Loureiro R. Sisinni A, et al. Among authors: perez r. J Am Heart Assoc. 2025 Jan 17:e037070. doi: 10.1161/JAHA.124.037070. Online ahead of print. J Am Heart Assoc. 2025. PMID: 39818971 Free article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Clinical Trial.
2,969 results